Delisting Determination,The Nasdaq Stock Market, LLC,
February 17, 2016, Rock Creek Pharmaceuticals, Inc.
The Nasdaq Stock Market, Inc. (the Exchange) has determined to
remove from listing the common stock of
Rock Creek Pharmaceuticals, Inc.
(the Company), effective at the opening of the trading
session on February 29, 2016. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rule 5550(b)(2). The Company was notified
of the Staffs determination on September 22, 2015.  The
Company appealed the determination to a Hearing Panel.
Upon review of the information provided by the Company,
the Panel issued a decision dated November 3, 2015, denying
the Company continued listing and notified the
Company that trading in the Companys
securities would be suspended on November 5, 2015.
The Company did not request a review of the Panels decision
by the Nasdaq Listing and Hearing Review Council. The
Listing Council did not call the matter for review.
The Panels Determination to delist the Company
became final on December 18, 2015.